| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.01 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |